MARIE ALICE LINDNER
Medical Practice in Delaware
License number
Pennsylvania MD042613E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Delaware
Wayne, PA 19087
Wayne, PA 19087
Personal information
See more information about MARIE ALICE LINDNER at radaris.comName
Address
Phone
44 Rolling Ridge Dr, Milton, PA 17847
631 Hollow Rd, Radnor, PA 19087
Pittston, PA
60 Rolling Ridge Ct, Milton, PA 17847
60 Rorng Ridge, Milton, PA 17847
Professional information
See more information about MARIE ALICE LINDNER at trustoria.com
Scientific Licensing, Business Development At Shire Pharmaceuticals
Scientific Licensing, Business Development At Shire Pharmaceuticals
Position:
Senior Director at Shire Pharmaceuticals, President at BioValue Creation, LLC (Sole Proprietorship)
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
Shire Pharmaceuticals
- Wayne, PA since Aug 2012
-
Senior Director
BioValue Creation, LLC
since Jan 2007
-
President
Optimeos Life Sciences, LLC
Feb 2010 - Jul 2012
-
Partner
BioAdvance
Feb 2008 - Jul 2012
-
Venture Partner
Plexus Ventures
Apr 2007 - Dec 2009
-
Senior Consultant
Embera NeuroTherapeutics, Inc
Aug 2005 - May 2009
-
Board Member
Isolagen Therapeutics, Inc
Jul 2005 - Nov 2006
-
SVP, Medical & Business Affairs
BTG, plc
Jun 2003 - May 2005
-
VP, Business Development
BTG International Inc.
2003 - 2005
-
VP Business Development
Elan Drug Delivery
Jan 2000 - May 2003
-
VP, Medical Market Strategy
SmithKline Beecham
1997 - 2000
-
Group Director, Alliance&Technology Group
Rhone-Poulenc Rorer
Jul 1991 - Apr 1997
-
Asst Director through Executive Director
Hospital of the University of Pennsylvania
Jul 1989 - Jul 1991
-
Assistant Professor of Medicine, Cardiology
The Childrens Hospital of Philadelphia
Jul 1988 - Jul 1991
-
Assistant Professor of Pediatrics
Education:
Chicago Medical School at Rosalind Franklin U-Med & Science 1975 - 1978
MD Washington University in St. Louis 1970 - 1973
BA, Biology
MD Washington University in St. Louis 1970 - 1973
BA, Biology
Languages:
French
Methods For Culturing Dermal Cells For Treatment Of Skin Injuries Such As Burns
Methods For Culturing Dermal Cells For Treatment Of Skin Injuries Such As Burns
US Patent:
2010030, Dec 2, 2010
Filed:
Dec 27, 2007
Appl. No.:
12/521262
Inventors:
John Maslowski - Pottstown PA, US
Myrna F. Thomas - Hainesport NJ, US
Marie A. Lindner - Radnor PA, US
Myrna F. Thomas - Hainesport NJ, US
Marie A. Lindner - Radnor PA, US
International Classification:
A61K 35/36, A61P 17/02, C12N 5/07
US Classification:
424 937, 435379, 435325, 435408
Abstract:
The present invention relates to novel methods of growing or otherwise producing unpassaged or minimally-passaged dermal cells from a small biopsy specimen for treating skin injuries significantly larger than the biopsy.
Dr. Marie A Lindner, Radnor PA - MD (Doctor of Medicine)
Dr. Marie A Lindner, Radnor PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
631 Hollow Rd, Radnor 19087
Certifications:
Internal Medicine, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1978
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1978
Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
Methods For Culturing Minimally-Passaged Fibroblasts And Uses Thereof
US Patent:
2010029, Nov 25, 2010
Filed:
Aug 29, 2007
Appl. No.:
12/438932
Inventors:
John Maslowski - Pottstown PA, US
Myrna F. Thomas - Hainesport NJ, US
Marie A. Lindner - Radnor PA, US
Myrna F. Thomas - Hainesport NJ, US
Marie A. Lindner - Radnor PA, US
Assignee:
Isolagen Technologies, Inc. - Exton PA
International Classification:
A61K 35/12, C12N 5/02, A61P 17/02, A61P 19/04
US Classification:
424 937, 435378
Abstract:
The present invention relates to novel methods of growing at least 100 million minimally-passaged fibroblasts from a small biopsy specimen. The invention includes methods wherein a small biopsy specimen is seeded directly into a large tissue culture flask, and passaged no more than three times.
Nanoparticulate Statin Formulations And Novel Statin Combinations
Nanoparticulate Statin Formulations And Novel Statin Combinations
US Patent:
2011002, Feb 3, 2011
Filed:
Mar 6, 2006
Appl. No.:
11/367716
Inventors:
Eugene R. Cooper - Berwyn PA, US
Douglas Hovey - Trooper PA, US
Greta Cary - Landsdale PA, US
Marie Lindner - Radnor PA, US
Elaine Liversidge - West Chester PA, US
Gary G. Liversidge - West Chester PA, US
Tuula Ryde - Malvern PA, US
Douglas Hovey - Trooper PA, US
Greta Cary - Landsdale PA, US
Marie Lindner - Radnor PA, US
Elaine Liversidge - West Chester PA, US
Gary G. Liversidge - West Chester PA, US
Tuula Ryde - Malvern PA, US
International Classification:
A61K 31/717, A61K 9/14, A61K 31/351, A61K 9/12, A61K 31/56, A61K 31/455, A61K 31/397, A61P 3/06, A61P 9/00, A61P 25/28
US Classification:
424489, 514460, 424 43, 514171, 514356, 51421002, 514 57
Abstract:
The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.
Nanoparticulate Statin Formulations And Novel Statin Combinations
Nanoparticulate Statin Formulations And Novel Statin Combinations
US Patent:
2008021, Sep 4, 2008
Filed:
Oct 31, 2007
Appl. No.:
11/980586
Inventors:
Eugene R. Cooper - Berwyn PA, US
Douglas Hovey - Trooper PA, US
Greta Cary - Landsdale PA, US
Marie Lindner - Radnor PA, US
Elaine Liversidge - West Chester PA, US
Gary G. Liversidge - West Chester PA, US
Tuula Ryde - Malvern PA, US
Douglas Hovey - Trooper PA, US
Greta Cary - Landsdale PA, US
Marie Lindner - Radnor PA, US
Elaine Liversidge - West Chester PA, US
Gary G. Liversidge - West Chester PA, US
Tuula Ryde - Malvern PA, US
International Classification:
A61K 9/14, A61K 31/366, A61P 3/06
US Classification:
424489, 514460
Abstract:
The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.